Br J Cardiol 2011;18:219–22 10.5837/bjc.2011.002
The purpose of this review is to give a broad overview of the role of patent foramen ovale (PFO) in disease. The embryological origins of...
Read More
Br J Cardiol 2011;18:224-228 10.5837/bjc.2011.003
Insulin remains an important treatment for patients with type 1 and type 2 diabetes. Insulin is given to patients with type 1 diabetes as a...
Read More
Br J Cardiol 2011;18:231–2 10.5837/bjc.2011.004
Sonographer- and nurse-led clinics were developed at a cardiothoracic centre and a sonographer-led clinic at a district general hospital (DGH). Common database fields were adopted...
Read More
Br J Cardiol 2011;18:233-237 10.5837/bjc.2011.005
Alcohol septal ablation (ASA) is an alternative therapeutic method to the gold-standard surgical myectomy in the treatment of symptomatic left ventricular outflow tract (LVOT) obstruction...
Read More
Br J Cardiol 2011;18:238-240 10.5837/bjc.2011.006
In order to determine the taking of regular aspirin within a representative community sample of adults residing in the south Wales county of Caerphilly, we...
Read More
Br J Cardiol 2011;18:246-248 10.5837/bjc.2011.009
Platelet activation is an important part of the pathophysiology of acute coronary syndromes. Inhibition of this by antiplatelet agents forms an important part of the...
Read More
Br J Cardiol 2011;18:241-242 10.5837/bjc.2011.007
A 27-year-old Arab woman with history of seronegative rheumatoid arthritis for four years presented with a three-day history of multiple joint pains and swelling, along with...
Read More
Br J Cardiol 2011;18:243-245 10.5837/bjc.2011.008
Outcome in patients with peripartum cardiomyopathy (PPCM) is variable. Recovery of left ventricular function is observed in between 23% and 51% of cases at six...
Read More
Br J Cardiol 2011;18:167–69
The glucagon-like peptide-1 (GLP-1) receptor agonists are a new class of injected drugs for the treatment of type 2 diabetes. They mimic the action of...
Read More
Br J Cardiol 2011;18:171–76
We developed and piloted an innovative family-centred preventive cardiology programme (MyAction) that aimed to both integrate the care of patients with vascular disease with that...
Read More